The gap between trailing and forward P/E suggests that trailing earnings are depressed by divestiture-related noise and a weak 2026Q1 margin, so the trailing multiple overstates the true cost of ownership. The forward EV/EBITDA of 14.87 against a trailing 29.48 shows the same compression, which investors should treat as conditional on the Q2 2026 beat and raised guidance holding up. Relative to peers such as Waters at 42.11 P/E and Mettler-Toledo at 39.82, the forward multiple sits at a discount to the group, but the peer set itself carries high multiples, so the discount may reflect Revvity's lower growth durability rather than mispricing.

Gross margin has rebounded to 57.4%, but operating margin of 13.1% and net margin of 8.5% suggest that below-the-line costs, including amortization from the BioLegend acquisition, still absorb a meaningful share of gross profit. The volatility in gross margin, which fell to 43.8% in 2025Q4, indicates that mix and one-time items distort quarterly comparisons. Investors should focus on operating margin trajectory as the cleaner read on underlying earning power while the divestiture-driven base resets.

With goodwill representing roughly 57% of total assets, the denominator of invested capital is dominated by acquisition premiums that generate limited incremental return at current margin levels. ROE and ROA show the same low, flat pattern, suggesting capital is not yet compounding. The sector comparison is less favorable than the trailing numbers imply, since Mettler-Toledo reports 40.0% ROIC and Waters 20.1%, pointing to a structural gap that management's transformation strategy would need to close.

Total debt has fallen to $2.8B against $7.3B of equity, yielding a D/E of 0.38, which indicates modest refinancing exposure. However, the D/EBITDA ratio is elevated in most quarters and appears sensitive to quarterly EBITDA swings, which warrants further investigation before treating leverage as low-risk on a trailing basis. Interest coverage has recovered to 4.7 in 2026Q3, a level that suggests debt service is currently manageable.

The decline in current and quick ratios tracks the drawdown in cash from roughly $1.2B to $593M, consistent with the acquisition spending observed in cash flow activity. A quick ratio of 2.1 in 2026Q3 still indicates reasonable coverage of near-term obligations without reliance on inventory, but the trend suggests the buffer is shrinking. Under severe stress, the company's reliance on operating cash generation would become more important than balance sheet reserves.